Skip to main content
Features
Assistant
AI grounded in research
Search
Full-text citation search
Collections
Organize and monitor papers
All Features →
Integrations
MCP
Connect AI agents to Scite
API
Programmatic data access
Holdings
Full-text via your library
Zotero Plugin
Citation data in Zotero
Browser Extension
Citation badges anywhere
All Integrations →
Data
Rankings
Pricing
Log In
Start Free Trial
Features
Assistant
AI grounded in research
Search
Full-text citation search
Collections
Organize and monitor papers
All Features →
Integrations
MCP
Connect AI agents to Scite
API
Programmatic data access
Holdings
Full-text via your library
Zotero Plugin
Citation data in Zotero
Browser Extension
Citation badges anywhere
All Integrations →
Data
Rankings
Pricing
Log In
Start Free Trial
Jørn Herrstedt
Sign up to set email alerts
386
Publications
13,019
Citation Statements Received
5,735
Citation Statements Given
How they've been cited
16,009
350
12,602
67
How they cite others
11,342
318
5,379
38
Affiliations
Odense University Hospital
,
Zealand University Hospital
Publications
Order By: Most citations
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
Mirza
1
,
Monk
2
,
Herrstedt
3
et al.
2016
N Engl J Med
Abstract
Show
2,602
71
2,280
11
Get access via publisher
Add to collection
Cite
Management of febrile neutropaenia: ESMO Clinical Practice Guidelines
Klastersky
1
,
de Naurois
2
,
Rolston
3
et al.
2016
Annals of Oncology
802
14
795
4
Get access via publisher
Add to collection
Cite
The Multinational Association for Supportive Care in Cancer Risk Index: A Multinational Scoring System for Identifying Low-Risk Febrile Neutropenic Cancer Patients
Klastersky
1
,
Paesmans
2
,
Rubenstein
3
et al.
2000
JCO
Abstract
Show
1,158
15
768
8
Get access via publisher
Add to collection
Cite
Management of Cancer Cachexia: ASCO Guideline
Roeland
1
,
Bohlke
2
,
Baracos
3
et al.
2020
JCO
Abstract
Show
671
6
702
0
Get access via publisher
Add to collection
Cite
2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients
Roila
1
,
Molassiotis
2
,
Herrstedt
3
et al.
2016
Annals of Oncology
597
2
621
2
Get access via publisher
Add to collection
Cite
Bone health in cancer patients: ESMO Clinical Practice Guidelines
Coleman
1
,
Body
2
,
Aapro
3
et al.
2014
Annals of Oncology
Abstract
Show
584
2
540
0
Get access via publisher
Add to collection
Cite
Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference
Roila
1
,
Herrstedt
2
,
Aapro
3
et al.
2010
Annals of Oncology
680
9
522
1
Get access via publisher
Add to collection
Cite
Effect of a multimodal high intensity exercise intervention in cancer patients undergoing chemotherapy: randomised controlled trial
Adamsen
1
,
Quist
2
,
Andersen
3
et al.
2009
BMJ
Abstract
Show
484
27
465
4
Get access via publisher
Add to collection
Cite
1
2
3